Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia
Hao-Qi Zheng,Yu-Cong Ma,Yu-Quan Chen,Yan-Yue Xu,Yan-Lin Pang,Li Liu
DOI: https://doi.org/10.2147/IDR.S372940
2022-07-29
Infection and Drug Resistance
Abstract:Hao-Qi Zheng, 1 Yu-Cong Ma, 1 Yu-Quan Chen, 2 Yan-Yue Xu, 1 Yan-Lin Pang, 1 Li Liu 1 1 Department of Pediatrics, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China; 2 Institute of Medical Information/Library, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100020, People's Republic of China Correspondence: Li Liu, Department of Pediatrics, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China, Email Purpose: Severe mycoplasma pneumoniae (MP) pneumonia can cause bronchiolitis obliterans (BO). In order to improve the prognosis of BO, it is necessary to grasp the clinical characteristics and risk factors of BO after severe MP pneumonia and intervene as soon as possible. Patients and Methods: This study retrospectively analyzed the clinical data of 110 patients with severe MP pneumonia, and divided them into BO group (22 cases) and non-BO group (88 cases). The clinical characteristics of BO group were analyzed, and the clinical data of two groups were compared to identify the risk factors of BO. Results: At the time of diagnosis, all BO patients had symptoms of cough and wheezing, and 10 (45.45%) had decreased exercise intolerance. Lung function showed moderate to severe obstructive ventilatory dysfunction, high-resolution computed tomography (HRCT) showed mosaic perfusion patterns. Multivariate binomial regression analysis showed that higher levels of serum lactate dehydrogenase (LDH) and hypoxemia were independent risk factors for BO after severe MP pneumonia. Conclusion: Higher levels of serum LDH and hypoxemia were independent risk factors for BO after severe MP pneumonia. For patients with risk factors, clinicians should regular follow-up for early diagnosis and intervention of BO. Keywords: children, bronchiolitis obliterans, mycoplasma pneumoniae pneumonia, post-infectious bronchiolitis obliterans, risk factors Mycoplasma pneumoniae (MP) is a common pathogen of community-acquired pneumonia in patients and MP pneumonia accounts for about 10–40% of community-acquired pneumonia. 1,2 MP infections are usually mild or self-limited, but in recent years, the incidence of MP pneumonia has been increasing. In addition, cases of severe MP pneumonia and macrolide-resistant MP (MRMP) pneumonia also are increasing, which can be life-threatening in severe cases. 3–5 Severe MP pneumonia and MRMP pneumonia can present with serious complications, including acute respiratory distress syndrome, bronchiolitis obliterans (BO) and so on. 6 Post-infectious bronchitis obliterans (PIBO) is a chronic obstructive pulmonary disease secondary to a severe lower respiratory tract infection in childhood, which is characterized by inflammation and fibrotic narrowing of bronchioles. 7 MP is a common pathogen of PIBO. However, there were few reports on the clinical characteristics and risk factors of BO after severe MP pneumonia. In order to improve the understanding of BO after severe MP pneumonia, the primary aim of the study was to summarize the clinical characteristics of BO after severe MP pneumonia and explore the potential risk factors, so as to provide a theoretical basis for early recognition and intervention of BO after severe MP pneumonia. A total of 22 patients with severe MP pneumonia who developed into PIBO were hospitalized in the Pediatric Respiratory Department of the First Hospital of Jilin University from 2014 to 2021. The control group was randomly selected, with a ratio of 4:1, and the year of severe MP pneumonia was matched. Follow-up for at least 1 year confirmed that there was no possibility of PIBO, and 88 patients with severe MP pneumonia were selected as the control group. The study was approved by the research ethics committees of First Hospital of Jilin University (Approval Number No.2021-747). Inclusion Criteria: a. Patients were younger than 14 years old; b. All the Patients met the diagnostic criteria for severe pneumonia in guidelines for the Management of Community-acquired Pneumonia in children (2013); 8 c. Single serum MP-IgM titer ≥1:160. Exclusion Criteria: a. Patients with bone marrow transplantation or organ transplantation; b. Patients with connective tissue diseases; c. Patients who contracted severe pneumonia again due to infection with other pathogens after the first diagnosis; d. Patients with incomplete clinical data. PIBO diagnostic criteria: 9,10 a. Persistent or recurrent cough, wheezing, tachypnea, and decreased exercise intolerance for at least 6 weeks after acute severe MP pneumonia; b. There are extensive wheezing and moist crackles in both lungs; c. High-resolution -Abstract Truncated-
pharmacology & pharmacy,infectious diseases